,
, , p.23
, , p.23
, , p.23
Histoire naturelle de la maladie de Crohn????????????????? 25 ,
Présentation clinique au diagnostic???????????????, p.25 ,
Evolution de l'atteinte luminale?????????????????? 25 ,
, , vol.26
Evaluation de l'activité de la maladie de Crohn?????????, ?????, vol.29 ,
, A. Evaluation clinique???????????????????????, p.29
, Evaluation biologique??????????????????????, p.29
, C. Evaluation endoscopique???????????????????...?, vol.30
,
,
,
, , p.33
Place de l'imagerie dans l'évaluation de l'activité dans la maladie de Crohn???, vol.34 ,
, , p.35
, , p.35
, ??, vol.36
IRM de diffusion dans la maladie de Crohn iléale et colique?????????, p.39 ,
Principes et technique de l'IRM de diffusion???????????, p.39 ,
Interprétation de l'IRM de diffusion????????????????, p.39 ,
Apport de l'IRM de diffusion??????????????????, p.40 ,
, VII. Scores radiologiques
, , vol.45
, , p.45
Problématique et construction de notre étude????????, p.49 ,
, ??, vol.50
, , vol.57
,
Treat to target: a proposed new paradigm for the management of Crohn ,
URL : https://hal.archives-ouvertes.fr/hal-00878688
, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.13, issue.6, pp.1042-1050, 2015.
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target, Am J Gastroenterol, vol.110, issue.9, pp.1324-1362, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01191653
Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn's disease, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.12, issue.6, pp.978-85, 2014. ,
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease, J Crohns Colitis, vol.5, issue.5, pp.477-83, 2011. ,
Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease, Aliment Pharmacol Ther, vol.43, issue.3, pp.317-350, 2016. ,
European evidence based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, vol.7, issue.12, pp.982-1018, 2013. ,
Colonoscopic perforations in inflammatory bowel disease: a retrospective study in a French referral centre, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, vol.45, issue.7, pp.569-72, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01700991
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidencebased consensus guidelines, J Crohns Colitis, vol.7, issue.7, pp.556-85, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01704202
,
, Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease, Gut, vol.59, issue.8, pp.1056-65, 2010.
Accuracy of Diffusion-weighted Magnetic Resonance Colonography in Assessing Mucosal Healing and the Treatment Response in Patients with Ulcerative Colitis, J Crohns Colitis, vol.11, issue.6, pp.716-739, 2017. ,
Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease, Gastroenterology, vol.146, issue.2, pp.374-412, 2014. ,
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity, Inflamm Bowel Dis, vol.17, issue.8, pp.1759-68, 2011. ,
Increasing efficiency of MRE for diagnosis of Crohn's disease activity through proper sequence selection: a practical approach for clinical trials, 2017. ,
Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics, Gut, vol.64, issue.9, pp.1397-402, 2015. ,
Crohn's disease, Lancet, 2016. ,
Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD). Dig Liver Dis Off, J Ital Soc Gastroenterol Ital Assoc Study Liver, vol.45, issue.2, pp.89-94, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01701899
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, pp.749-53, 2006. ,
The natural history of adult Crohn's disease in population-based cohorts, Am J Gastroenterol, vol.105, issue.2, pp.289-97, 2010. ,
Diagnosis and treatment of perianal fistulas in Crohn disease, Ann Intern Med, vol.135, issue.10, pp.906-924, 2001. ,
Long-term evolution of disease behavior of Crohn's disease, Inflamm Bowel Dis, vol.8, issue.4, pp.244-50, 2002. ,
Clinical risk factors for complicated disease: how reliable are they?, Dig Dis Basel Switz, vol.30, issue.3, pp.67-72, 2012. ,
Development of the Crohn's disease digestive damage score, the Lémann score, Inflamm Bowel Dis, vol.17, issue.6, pp.1415-1437, 2011. ,
,
, European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management, J Crohns Colitis. janv, vol.11, issue.1, pp.3-25, 2017.
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study, Gastroenterology, vol.121, issue.2, pp.255-60, 2001. ,
Review article: the natural history of postoperative Crohn's disease recurrence, Aliment Pharmacol Ther, vol.35, issue.6, pp.625-658, 2012. ,
Predictability of the postoperative course of Crohn's disease, Gastroenterology, vol.99, issue.4, pp.956-63, 1990. ,
Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease, J Crohns Colitis, vol.5, issue.5, pp.484-98, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00692507
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials, Gut, vol.65, issue.9, pp.1447-55, 2016. ,
Infliximab, azathioprine, or combination therapy for Crohn's disease, N Engl J Med, vol.362, issue.15, pp.1383-95, 2010. ,
Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease, Scand J Gastroenterol, vol.47, issue.5, pp.528-565, 2012. ,
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial, Gastroenterology, vol.142, issue.5, pp.1102-1111, 2012. ,
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial, Gut, vol.63, issue.1, pp.88-95, 2014. ,
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease, Gastrointest Endosc, vol.63, issue.3, pp.433-442, 2006. ,
Fecal calprotectin and high sensitivity c-reactive protein levels to predict mucosal healing in patients with Crohn's disease. A subanalysis of the STORI study, Gut, vol.59, p.80, 20100. ,
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and MetaAnalysis, Am J Gastroenterol, vol.110, issue.6, pp.802-819, 2015. ,
Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy, Am J Gastroenterol, vol.97, issue.4, pp.947-53, 2002. ,
Vedolizumab induces long term mucosal healing in patients with Crohn's disease and ulcerative colitis, J Crohns Colitis, 2017. ,
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine, Gastrointest Endosc, vol.50, issue.5, pp.667-71, 1999. ,
Does methotrexate induce mucosal healing in Crohn's disease?, Inflamm Bowel Dis, vol.16, issue.3, pp.377-385, 2010. ,
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease, Aliment Pharmacol Ther, vol.34, issue.2, pp.125-170, 2011. ,
Diagnostics in inflammatory bowel disease: ultrasound, World J Gastroenterol, vol.17, issue.27, pp.3192-3199, 2011. ,
,
, Crohn's disease: factors associated with exposure to high levels of diagnostic radiation, Gut, vol.57, issue.11, pp.1524-1533, 2008.
Diagnostic ionizing radiation exposure in a population-based cohort of patients with inflammatory bowel disease, Am J Gastroenterol, vol.103, issue.8, pp.2015-2037, 2008. ,
Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis, Inflamm Bowel Dis, vol.17, issue.4, pp.984-93, 2011. ,
Apport de l'échographie et de l'entéro-IRM dans la maladie de Crohn (hors LAP), 2015. ,
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders, Radiology, vol.161, issue.2, pp.401-408, 1986. ,
URL : https://hal.archives-ouvertes.fr/hal-00349714
Hepatic hemangiomas: factors associated with T2 shine-through effect on diffusion-weighted MR sequences, Eur J Radiol, vol.83, issue.3, pp.468-78, 2014. ,
Utility of the diffusionweighted imaging for activity evaluation in Crohn's disease patients underwent magnetic resonance enterography, BMC Gastroenterol, vol.15, p.12, 2015. ,
Diffusion-weighted MRI in Crohn's disease: Current status and recommendations, J Magn Reson Imaging, 2016. ,
Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease, Acad Radiol, vol.16, issue.5, pp.597-603, 2009. ,
Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis, Inflamm Bowel Dis, vol.22, issue.3, pp.669-79, 2016. ,
MR Enterography for the Evaluation of Small-Bowel Inflammation in Crohn Disease by Using Diffusion-weighted Imaging without Intravenous Contrast Material: A Prospective Noninferiority Study, Radiology, vol.278, issue.3, pp.762-72, 2016. ,
Magnetic resonance enterocolonography in detecting erosion and redness in intestinal mucosa of patients with Crohn's disease, J Gastroenterol Hepatol, vol.30, issue.4, pp.667-73, 2015. ,
Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens, Eur Radiol, vol.24, issue.3, pp.619-648, 2014. ,
Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience, Abdom Imaging, vol.40, issue.5, pp.1068-74, 2015. ,
Longitudinal diffusion-weighted imaging changes in children with small bowel Crohn's disease: preliminary experience, Abdom Imaging, vol.40, issue.5, pp.1075-80, 2015. ,
Prediction of maintained mucosal healing in patients with Crohn's disease under treatment with infliximab using diffusion-weighted magnetic resonance imaging, Digestion, vol.89, issue.1, pp.49-54, 2014. ,
Diffusion-Weighted MR Enterography to Monitor Bowel Inflammation after Medical Therapy in Crohn's Disease: A Prospective Longitudinal Study, Korean J Radiol, vol.18, issue.1, pp.162-72, 2017. ,
Freebreathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn's disease, J Magn Reson Imaging, vol.29, issue.4, pp.880-886, 2009. ,
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease, Gut, vol.58, issue.8, pp.1113-1133, 2009. ,
,
, Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity, Am J Gastroenterol, vol.109, issue.1, pp.89-98, 2014.
,
, Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index, Eur J Radiol, vol.81, issue.9, pp.2080-2088, 2012.
Diffusionweighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease, Aliment Pharmacol Ther, vol.42, issue.4, pp.452-60, 2015. ,
What is the value of diffusion-weighted MRI in inflammatory bowel diseases? Hépato-Gastro Oncol Dig, vol.23, pp.850-60, 2016. ,
, Age at diagnosis, n (%) A1: <16 years
, 5) Associated upper digestive tract, n (%) 6 (6.3) Behaviour, n (%) B1: inflammatory 36 (37.5) B2: stricturing 33 (34.4) B3: penetrating 27 (28.1) Perianal disease, n (%) of remission, n (%) Infliximab, vol.38, p.20
, median (IQR), vol.6, pp.3-11
, , vol.4
, median (IQR) 11.1 (3-26) Nancy score, median (IQR), CRP, pp.6-6
, IQR, interquartile range Patient with endoscopy and a CDEIS>4 at baseline (n=15)
, Male/female, n (%) 10 (50)/10 (50) 9 (60)/6 (40) Age at inclusion, y, median (IQR), vol.37, pp.25-44
, Follow-up, y, median (IQR)
Treat to target: a proposed new paradigm for the management of Crohn's disease, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.13, pp.1042-1050, 2015. ,
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-toTarget, Am J Gastroenterol, vol.110, pp.1324-1338, 2015. ,
Endoscopic assessment and treating to target increase the likelihood of mucosal healing in patients with Crohn's disease, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.12, pp.978-985, 2014. ,
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease ,
, J Crohns Colitis, vol.5, pp.477-483, 2011.
Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease ,
, Aliment Pharmacol Ther, vol.43, pp.317-333, 2016.
European evidence based consensus for endoscopy in inflammatory bowel disease, J Crohns Colitis, vol.7, pp.982-1018, 2013. ,
Colonoscopic perforations in inflammatory bowel disease: a retrospective study in a French referral centre, Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, vol.45, pp.569-572, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01700991
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines, J Crohns Colitis, vol.7, pp.556-585, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01704202
Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease, Gut, vol.59, pp.1056-1065, 2010. ,
DOI : 10.1136/gut.2009.197665
Accuracy of Diffusion-weighted Magnetic Resonance Colonography in Assessing Mucosal Healing and the Treatment Response in Patients with Ulcerative Colitis, J Crohns Colitis, vol.11, pp.716-723, 2017. ,
Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease, Gastroenterology, vol.146, pp.374-382, 2014. ,
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity ,
, Inflamm Bowel Dis, vol.17, pp.1759-1768, 2011.
Increasing efficiency of MRE for diagnosis of Crohn's disease activity through proper sequence selection: a practical approach for clinical trials, 2017. ,
Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics, Gut, vol.64, pp.1397-1402, 2015. ,
Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity, Am J Gastroenterol, vol.109, pp.89-98, 2014. ,
Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease, J. Gastroenterol, 2016. ,
Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID), Gut, vol.30, pp.983-989, 1989. ,
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial, Gastroenterology, vol.142, pp.1102-1111, 2012. ,
Magnetic resonance enterography is feasible and reliable in multicenter clinical trials in patients with Crohn's disease, and may help select subjects with active inflammation, Aliment Pharmacol Ther, vol.43, pp.61-72, 2016. ,
Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopy, Am J Gastroenterol, vol.97, pp.947-953, 2002. ,
DOI : 10.1016/s0002-9270(02)03970-9
Development of the Crohn's disease digestive damage score, the Lémann score, Inflamm. Bowel Dis, vol.17, pp.1415-1422, 2011. ,
Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease, Gastroenterology, vol.148, pp.52-63, 2015. ,
Prevalence of Bowel Damage Assessed by CrossSectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome, J Crohns Colitis, vol.11, pp.274-280, 2017. ,